Literature DB >> 1163362

A study of factors that influence the severity of neonatal narcotic withdrawal.

E M Ostrea, C J Chavez, M E Strauss.   

Abstract

1. History is unreliable in assessing maternal drug habit. Morphine was detected in significant amounts in maternal and fetal urine regardless of whether the mother was on a methadone program or whether she denied any use of heroin during the last trimester of pregnancy. 2. Infants born to drug-addicted mothers were, in general, of birthweight normal and appropriate for gestational age (i.e., greater that 10th percentile). The infants born to mothers on a methadone clinic program had a higher birthweight compared to those whose mothers were not on any methadone program. 3. In order of frequency, the signs and symptoms of withdrawal were: central nervous system manifestations-fist sucking, irritability, tremors, sneezing, high-pitch cry, hypertonia; vasomotor in the form of stuffy nose; and gastrointestinal in the form of sweating, diarrhea, vomiting and yawning. Convulsions were not noted. No death occurred. 4. The severity of neonatal narcotic withdrawal did not correlate with the infant's gestational age, APGAR, sex or race; nor with maternal age, parity, duration of heroin addiction or duration of methadone intake. Also, it did not correlate with the total morphine level measured either in infant's or mother's urine or in cord blood. The serum levels of calcium and glucose were normal and identical in either mild or severe withdrawal. 5. The severity of neonatal withdrawal correlated significantly with the methadone dose per day of the mother (in initial, final or average dose). A maternal methadone dose of more than 20 mg per day was associated with a higher incidence of moderate to severe withdrawal in their babies. As a corollary, it was also noted that infants whose mothers were on a high methadone dose (i.e., greater than 20 mg per day) had a greater postnatal weight loss despite a significantly higher birthweight initially, and stayed in the hospital longer. 6. Finally, the modification of the environment to reduce external stimuli to the infant born to a drug-dependent mother, does not prevent or diminish the severity of neonatal narcotic withdrawal. Thus, there is no need to manage these infants in a special nursery.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1163362

Source DB:  PubMed          Journal:  Addict Dis        ISSN: 0094-0267


  8 in total

1.  Measurement of movement is an objective method to assist in assessment of opiate withdrawal in newborns.

Authors:  C O'Brien; R Hunt; H E Jeffery
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

Review 2.  Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.

Authors:  Davida M Schiff; Matthew R Grossman
Journal:  Semin Fetal Neonatal Med       Date:  2019-01-28       Impact factor: 3.926

3.  Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?

Authors:  C A Kuschel; L Austerberry; M Cornwell; R Couch; R S H Rowley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

4.  Sedatives for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18

5.  Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.

Authors:  Uma M Reddy; Jonathan M Davis; Zhaoxia Ren; Michael F Greene
Journal:  Obstet Gynecol       Date:  2017-07       Impact factor: 7.623

6.  Non-pharmacological care for opioid withdrawal in newborns.

Authors:  Adrienne Pahl; Leslie Young; Madge E Buus-Frank; Lenora Marcellus; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2020-12-21

7.  Opioid treatment for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-07-07

8.  Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome.

Authors:  Lori A Devlin; Janis L Breeze; Norma Terrin; Enrique Gomez Pomar; Henrietta Bada; Loretta P Finnegan; Kevin E O'Grady; Hendrée E Jones; Barry Lester; Jonathan M Davis
Journal:  JAMA Netw Open       Date:  2020-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.